Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

112 ta ish

Ish: From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis

  1. CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity

    Shigeaki Sunada, Hiroko Saito, Doudou Zhang +2

    Maqola20212 iqtibos
    ABI

  2. Molecular overlay-guided design of new CDK2 inhibitor thiazepinopurines: Synthesis, anticancer, and mechanistic investigations

    Ebtehal M. Husseiny, Hamada S. Abulkhair, Asmaa Saleh +3

    Maqola20232 iqtibos
    ABI

  3. LncRNA-DANCR: A valuable cancer related long non-coding RNA for human cancers

    Khaing Zar Thin, Xuefang Liu, Xiaobo Feng +2

    Sharh maqola20182 iqtibos
    ABI

  4. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR‐31/<i>CDK1</i>

    Zhao‐ju Tian, Shuang Cao, Li Cheng +6

    Maqola20182 iqtibos
    ABI

  5. Long noncoding RNA FOXD2‐AS1 promotes glioma cell cycle progression and proliferation through the FOXD2‐AS1/miR‐31/CDK1 pathway

    Jin Wang, Bingqiang Li, Cunzu Wang +3

    Maqola20192 iqtibos
    ABI

  6. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance

    Silpa Narayanan, Chao‐Yun Cai, Yehuda G. Assaraf +6

    Sharh maqola20192 iqtibos
    ABI

  7. miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A

    Xiaoru Xin, Yanan Lu, Sijie Xie +11

    Maqola20202 iqtibos
    ABI

  8. LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

    Xi Jin, Li‐Ping Ge, Da‐Qiang Li +4

    Maqola20202 iqtibos
    ABI

  9. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4

    Guannan He, Naren two ya Bao, Shuang Wang +3

    Maqola20212 iqtibos
    ABI

  10. LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p

    Huan Qu, Xingxing Li, Fei Chen +5

    Maqola20232 iqtibos
    ABI

  11. Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

    Erik B. Faber, Luxin Sun, Jian Tang +15

    Maqola20232 iqtibos
    ABI

  12. lncRNA PVT1 silencing inhibits gastric cancer cells’ progression via enhancing chemosensitivity to paclitaxel

    Bahar Naseri, Nader Farsad-Akhtar, Amirhossein Mardi +4

    Maqola20242 iqtibos
    ABI

  13. Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222

    Adam P. Dommer, Vishnu Kumarasamy, Jianxin Wang +6

    Maqola20252 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI